CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine, Inc. (NASDAQ:FMI) today announced that Michael J. Pellini,
M.D., president and chief executive officer, is scheduled to present at
the Bank of America Merrill Lynch 2014 Healthcare Conference on Tuesday,
May 13, 2014 at 1:40 p.m. P.T. in Las Vegas.
A live, listen-only webcast of the presentation can be accessed by
visiting the investors section of the Foundation Medicine website at
investors.foundationmedicine.com. A replay of the webcast will be
available shortly after the conclusion of the presentation and archived
on the company's website for two weeks following the presentation.
About Foundation Medicine
Foundation Medicine (NASDAQ: FMI) is a molecular information company
dedicated to a transformation in cancer care in which treatment is
informed by a deep understanding of the genomic changes that contribute
to each patient's unique cancer. The company's clinical assays,
FoundationOne for solid tumors and FoundationOne Heme for hematologic
malignancies, sarcomas and pediatric cancers, each provide a fully
informative genomic profile to identify the molecular alterations in a
patient's cancer and match them with relevant targeted therapies and
clinical trials. Foundation Medicine's molecular information platform
aims to improve day-to-day care for patients by serving the needs of
clinicians, academic researchers and drug developers to help advance the
science of molecular medicine in cancer. For more information, please
or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® and FoundationOne®
are registered trademarks of Foundation Medicine, Inc.
Pure Communications, Inc.
Khaled Habayeb, 617-418-2283
Source: Foundation Medicine, Inc.
News Provided by Acquire Media